Clinical trial
A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Non-Fasting Conditions
NCT00864617 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Non-Fasting Conditions
- Lead sponsor
- Actavis Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- May 31, 2005
- Enrollment
- 84 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy